Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can enzyme pills beat the bloat? new study tests a simple fix for IBS sufferers

NCT ID NCT07465562

First seen Mar 18, 2026 · Last updated Jun 22, 2026 · Updated 12 times

Summary

This study tested whether a dietary supplement containing digestive enzymes (Galactol®) could reduce bloating after meals in people with irritable bowel syndrome (IBS). 300 adults were randomly assigned to take the enzyme supplement plus a low-FODMAP diet, or just the diet alone, for 14 days. The main goal was to see if bloating intensity improved more with the supplement.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Urbino Carlo Bo

    Urbino, 61029, Italy

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

digestive enzyme supplement (alpha-galactosidase, beta-galactosidase, prolyl-endopeptidase)

What this could lead to

If it works, this could offer a simple, over-the-counter option to ease bloating after meals for people with IBS.

What could go wrong

This is a small, short-term study (14 days) with no blinding, so results may be influenced by placebo effects. The supplement is tested alongside a special diet, so it's unclear if the supplement alone would help.

Conditions

The condition(s) this trial relates to.

irritable bowel syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.